May 19, 2014 | Keystone Heart, a medical device company and the developer of the TriGuard Cerebral Protection Device, has successfully raised $14 million in a Series B round of financing led by OrbiMed. OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector, managing approximately $11 billion across public and private company investments.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments